Antonino Neri Selected Research

Antisense Oligonucleotides

11/2021	Specific targeting of the KRAS mutational landscape in myeloma as a tool to unveil the elicited antitumor activity.
1/2021	In Vitro Silencing of lncRNAs Using LNA GapmeRs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonino Neri Research Topics

Disease

88	Multiple Myeloma 05/2024 - 09/2002
85	Neoplasms (Cancer) 05/2024 - 08/2002
37	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2024 - 01/2008
11	Disease Progression 01/2024 - 04/2006
10	Plasma Cell Leukemia 01/2023 - 02/2005
9	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 12/2011
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 01/2016
7	Carcinogenesis 01/2021 - 10/2002
7	Paraproteinemias (Monoclonal Gammopathy) 01/2021 - 04/2005
5	Genomic Instability 04/2024 - 07/2015
5	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 04/2024 - 12/2006
5	Leukemia 01/2024 - 06/2014
5	Lymphoma (Lymphomas) 12/2023 - 08/2003
4	Monoclonal Gammopathy of Undetermined Significance 01/2023 - 09/2009
4	Trisomy (Trisomies) 01/2020 - 09/2003
4	Thyroid Neoplasms (Thyroid Cancer) 01/2020 - 10/2015
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2016 - 10/2004
3	COVID-19 08/2023 - 07/2020
3	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2023 - 01/2021
3	Chromosome Aberrations (Chromosome Abnormalities) 08/2014 - 09/2011
3	Genetic Translocation (Chromosomal Translocation) 03/2007 - 08/2003
2	Anemia 04/2024 - 10/2023
2	T-Cell Lymphoma (Lymphoma, T Cell) 04/2024 - 12/2023
2	Infections 01/2024 - 01/2017
2	Oncogene Addiction 01/2020 - 12/2017
2	Breast Neoplasms (Breast Cancer) 01/2017 - 01/2017
2	Bone Diseases (Bone Disease) 09/2015 - 11/2014
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 11/2014 - 04/2012
2	Chromosomal Instability (Chromosome Stability) 07/2014 - 08/2009
2	Hypoxia (Hypoxemia) 05/2014 - 12/2007
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2013 - 10/2002
2	Lymphocytosis 01/2013 - 01/2008
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 07/2005 - 10/2004
2	Squamous Cell Carcinoma of Head and Neck 01/2005 - 03/2004
1	Primary Myelofibrosis (Myelosclerosis) 04/2024
1	Sudden Death 01/2024
1	Heart Failure 01/2024
1	Hemorrhage 01/2024

Drug/Important Bio-Agent (IBA)

29	MicroRNAs (MicroRNA)IBA 08/2021 - 08/2008
17	Long Noncoding RNAIBA 12/2023 - 03/2016
14	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 03/2004
13	Biomarkers (Surrogate Marker)IBA 12/2023 - 09/2002
10	Proteins (Proteins, Gene)FDA Link 04/2024 - 08/2002
10	Messenger RNA (mRNA)IBA 01/2023 - 10/2002
10	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2020 - 02/2005
8	Lenalidomide (CC 5013)FDA Link 01/2024 - 04/2013
8	LigandsIBA 09/2023 - 04/2013
7	Proteasome InhibitorsIBA 10/2023 - 03/2008
6	carfilzomibIBA 08/2023 - 01/2020
6	Rituximab (Mabthera)FDA Link 01/2023 - 10/2015
6	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 04/2016
5	ibrutinibIBA 01/2024 - 10/2020
5	Bortezomib (Velcade)FDA Link 08/2023 - 03/2008
5	elotuzumabIBA 01/2023 - 01/2022
5	RNA (Ribonucleic Acid)IBA 12/2022 - 07/2015
5	Protein Isoforms (Isoforms)IBA 11/2021 - 07/2005
5	Small Interfering RNA (siRNA)IBA 10/2019 - 12/2007
5	Cyclin D1IBA 10/2015 - 09/2003
4	Monoclonal AntibodiesIBA 05/2024 - 04/2013
4	CytokinesIBA 04/2024 - 01/2018
4	Anaplastic Lymphoma KinaseIBA 12/2023 - 12/2006
4	venetoclaxIBA 01/2023 - 09/2021
4	Interleukin-6 (Interleukin 6)IBA 10/2021 - 04/2013
4	Untranslated RNA (Noncoding RNA)IBA 04/2021 - 06/2013
4	Proteasome Endopeptidase Complex (Proteasome)IBA 10/2020 - 03/2008
4	mouse MIRN29 microRNAIBA 12/2017 - 10/2012
4	Transcription Factors (Transcription Factor)IBA 08/2015 - 12/2011
4	Cyclin D3IBA 01/2005 - 08/2003
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2020 - 10/2015
3	fludarabineIBA 11/2020 - 03/2012
3	Phosphotransferases (Kinase)IBA 10/2020 - 11/2009
3	Circulating Tumor DNAIBA 08/2020 - 01/2018
3	enzastaurinIBA 09/2011 - 07/2008
2	Immunomodulating AgentsIBA 10/2023 - 04/2013
2	NAD (NADH)IBA 02/2023 - 01/2018
2	pomalidomideIBA 01/2023 - 04/2013
2	Estrogen Receptor alphaIBA 01/2023 - 09/2022
2	GTP-Binding Proteins (G-Protein)IBA 01/2023 - 09/2022
2	Antisense OligonucleotidesIBA 11/2021 - 01/2021
2	Bendamustine Hydrochloride FDA Link 01/2021 - 01/2018
2	Immunoglobulins (Immunoglobulin)IBA 10/2020 - 04/2013
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018 - 01/2015
2	Aromatase InhibitorsIBA 01/2017 - 01/2017
2	Thalidomide (Thalomid)FDA Link 04/2016 - 08/2005
2	Inosine Triphosphate (ITP)IBA 11/2014 - 04/2012
2	Histone Deacetylase InhibitorsIBA 08/2012 - 02/2010
2	Protein Kinase CIBA 03/2009 - 07/2008
2	Protein Kinase C betaIBA 03/2009 - 07/2008
2	AdiponectinIBA 01/2009 - 11/2008
2	Cyclin DIBA 03/2007 - 10/2005
2	AntigensIBA 04/2006 - 04/2005
1	fms-Like Tyrosine Kinase 3IBA 05/2024
1	Janus Kinase InhibitorsIBA 04/2024
1	N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA 04/2024
1	ChromatinIBA 04/2024
1	selinexorIBA 03/2024

Therapy/Procedure

32	Therapeutics 05/2024 - 09/2003
7	Drug Therapy (Chemotherapy) 10/2023 - 09/2003
3	Salvage Therapy 12/2022 - 01/2022
2	Immunotherapy 12/2021 - 04/2005